These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18424732)

  • 1. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
    Vasl J; Prohinar P; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2008 May; 180(9):6107-15. PubMed ID: 18424732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4.
    Prohinar P; Rallabhandi P; Weiss JP; Gioannini TL
    J Immunol; 2010 Apr; 184(8):4362-7. PubMed ID: 20212095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.
    Rallabhandi P; Bell J; Boukhvalova MS; Medvedev A; Lorenz E; Arditi M; Hemming VG; Blanco JC; Segal DM; Vogel SN
    J Immunol; 2006 Jul; 177(1):322-32. PubMed ID: 16785528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin.
    Teghanemt A; Re F; Prohinar P; Widstrom R; Gioannini TL; Weiss JP
    J Biol Chem; 2008 Jan; 283(3):1257-1266. PubMed ID: 17977838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
    Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
    Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2.
    Vašl J; Oblak A; Peternelj TT; Klett J; Martín-Santamaría S; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2016 Mar; 196(5):2309-18. PubMed ID: 26826249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.
    Visintin A; Halmen KA; Latz E; Monks BG; Golenbock DT
    J Immunol; 2005 Nov; 175(10):6465-72. PubMed ID: 16272300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
    Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
    J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of monomeric endotoxin from MD-2 to CD14: characterization and functional consequences.
    Teghanemt A; Prohinar P; Gioannini TL; Weiss JP
    J Biol Chem; 2007 Dec; 282(50):36250-6. PubMed ID: 17934216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
    Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
    mBio; 2012; 3(4):. PubMed ID: 22872782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
    Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
    Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.
    Gray P; Michelsen KS; Sirois CM; Lowe E; Shimada K; Crother TR; Chen S; Brikos C; Bulut Y; Latz E; Underhill D; Arditi M
    J Immunol; 2010 Jun; 184(11):6359-66. PubMed ID: 20435923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide.
    Kondo Y; Ikeda K; Tokuda N; Nishitani C; Ohto U; Akashi-Takamura S; Ito Y; Uchikawa M; Kuroki Y; Taguchi R; Miyake K; Zhang Q; Furukawa K; Furukawa K
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4714-9. PubMed ID: 23471986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness.
    Re F; Strominger JL
    J Immunol; 2003 Nov; 171(10):5272-6. PubMed ID: 14607928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.